Category: Clinical Research/Diagn.
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
Three Labs in Japan and Spain to Receive Novel Compact Ascend Evo 1.0 GHz Magnets UTRECHT, The Netherlands–(BUSINESS WIRE)– At the Euromar 2022 Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHzNMR magnets for structural biology applications and clinical research in single-story laboratories. The new Ascend Evo... Read more
Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment
ETTLINGEN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRiskPACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, using a multiplexed combination of biomarkers discovered at the Australian National Phenome Center (ANPC) at Murdoch University, under Director Jeremy Nicholson. The PhenoRiskPACS™ RuO test is promising for research... Read more
GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at #ASCO22
Collaborations demonstrate role as a core partner in multidisciplinary cancer care Chicago, US – June 3, 2022: From early detection to remote monitoring and data sharing, GE Healthcare’s innovative suite of diagnostic and treatment technologies are designed to help improve detection, clinical efficiency, operational efficiency, and outcomes for cancer patients. “GE Healthcare is collaborating with health... Read more